Hailshadow/iStock via Getty Images Relief Therapeutics ( OTCQB:RLFTY ) has signed a non-binding letter of intent with Renexxion, a privately-held U.S.-based clinical-stage biotechnology company, for a reverse merger, the companies said on Monday.
The transaction, if entered into and completed, is expected to strengthen the combined company's competitive.